Search Results
Feb 10, 2026, 10:53 ET Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine
This notable finding, the Beefeater Shear, is a shear zone corridor mapped at widths of up to 10-15 meters and a result of a comprehensive Stage III technical review focusing on the Northern Block. This included high-resolution underground mapping at the DAM and regional structural analysis. More
More news about: Locksley Resources
Feb 10, 2026, 10:30 ET YBI's Engine Tech Incubator Launches Landing Zone: A Free, Global Advanced Manufacturing Market Entry Lab
manufacturing assets and expertise.World-Class Instruction at No CostDr. Scott Shane, YBI Entrepreneur-in-Residence and A. Malachi Mixon III Professor of Entrepreneurial Studies at Case Western Reserve University, leads the program. Dr. Shane has published 95 scholarly articles and 15 books
More news about: YBI
Feb 10, 2026, 10:14 ET Five Veterans Experience Super Bowl Thanks to Veteran Tickets Foundation
unique Tickets forTroops program."We're incredibly fortunate to receive support from our members and donors," says Michael A. Focareto III, Vet Tix Founder, CEO, and U.S. Navy veteran. "We invest those funds in ticket purchases year-round—from local concerts to major sporting events like
More news about: Veteran Tickets Foundation
Feb 10, 2026, 10:03 ET STAND TOGETHER VENTURES LAB, CUBIT CAPITAL, 8VC, AND GSV INVEST IN TAP TO ACCELERATE AI-POWERED WORKFORCE DEVELOPMENT FOR ADVANCED MANUFACTURING
firm focused on the $7+ trillion global education and workforce skills sector. The firm manages and is currently investing out of GSV Ventures Fund III, backing innovative entrepreneurs across the "Pre-K to Gray" Arc of Learning and Skills. GSV has made investments in industry leaders, including ClassDojo,
More news about: Stand Together Ventures Lab
Feb 10, 2026, 09:45 ET YBI's Engine Tech Incubator Launches Landing Zone: A Free, Global Advanced Manufacturing Market Entry Lab
manufacturing assets and expertise.World-Class Instruction at No CostDr. Scott Shane, YBI Entrepreneur-in-Residence and A. Malachi Mixon III Professor of Entrepreneurial Studies at Case Western Reserve University, leads the program. Dr. Shane has published 95 scholarly articles and 15 books
More news about: YBI
Feb 10, 2026, 09:00 ET PARAMOUNT ENHANCES ITS SUPERIOR $30 PER SHARE ALL-CASH OFFER FOR WARNER BROS. DISCOVERY AND PROVIDES UPDATE ON REGULATORY PROGRESS
meetings with and providing customary information to (i) the Antitrust Division of the U.S. Department of Justice, (ii) the European Commission, and (iii) the Competition and Markets Authority in the United Kingdom, among other bodies.On February 9, 2026, Paramount certified to the U.S. Department
More news about: Paramount Skydance Corporation
Feb 10, 2026, 08:36 ET Learning Ally Audiobook Solution Receives Prestigious Endorsement from the Council of Administrators of Special Education (CASE)
this endorsement from CASE, an organization that represents thousands of dedicated special education leaders across North America," said Howard Bell III, CEO of Learning Ally. "This distinction validates our 77-year mission to ensure that every student, regardless of their learning difference, has
More news about: Learning Ally
Feb 10, 2026, 08:30 ET NATURE'S MIRACLE HOLDING INC. SIGNS MOU FOR $150 MILLION EPC CONTRACT TO BUILD LARGE-SCALE INDOOR CANNABIS FACILITY IN CALIFORNIA
securities; (ii) the occurrence of any unforeseen event that would impact continued listing of Nature's Miracle's securities on the Nasdaq exchange; (iii) changes in the competitive industries in which Nature's Miracle operates, variations in operating performance across competitors, changes in laws and
More news about: Nature's Miracle Holding Inc.
Feb 10, 2026, 08:07 ET On Site: "2026 China Forum on Source Innovation in New Drug Discovery" Concludes Successfully
Among more than 60 collaborative programs, over 10 have successfully completed IND (Investigational New Drug) filings, and three have advanced to Phase III clinical trials.Looking ahead, Sanyou Bio will advance its "5-5 Strategic Initiative", leveraging the combined power of AI technologies and super-trillion-scale
More news about: Sanyou Bio
Feb 10, 2026, 08:00 ET Dingdong Announces Intention to Utilize Substantial Majority of Proceeds from Sale of China Operations for Share Repurchase Plans and/or Dividends upon Closing of Transaction
closing conditions will be satisfied or waived, (ii) the Transaction will close and the Company will receive cash proceeds from the Transaction and (iii) any share repurchase plans or dividends will be made. As the closing of the Transaction is subject to substantial uncertainty and factors beyond the
More news about: Dingdong (Cayman) Limited
Feb 10, 2026, 07:52 ET Sonata Software Achieves AWS Premier Tier Status in the AWS Partner Network
compliance. We enable our clients to leverage AI in three different ways: i) driving efficiencies, ii) driving higher consumer experience/modern sales, and iii) driving innovative business models. We have launched bleeding edge Agentic AI offering – AgentBridge – that enables enterprises to usher in the era
More news about: Sonata Software
Feb 10, 2026, 07:48 ET Sonata Software Achieves AWS Premier Tier Status in the AWS Partner Network
compliance. We enable our clients to leverage AI in three different ways: i) driving efficiencies, ii) driving higher consumer experience/modern sales, and iii) driving innovative business models. We have launched bleeding edge Agentic AI offering – AgentBridge – that enables enterprises to usher in the era
More news about: Sonata Software
Feb 10, 2026, 07:14 ET Einride to Appoint Former NVIDIA Executive Gary Hicok to Board of Directors
[email protected] Merger Corp. IIIEric RosenfeldChief SPAC Officer, Legato Merger Corp. III[email protected] This
More news about: Einride
Feb 10, 2026, 07:10 ET INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - RARE
Ultragenyx' Phase III Orbit study would fail to achieve a statistically significant reduction in annualized fracture rate ("AFR"), such that the second interim analysis could be performed and presented to the investing public; and (ii) in truth, Ultragenyx' optimism in the Phase III Orbit study's results
More news about: Robbins Geller Rudman & Dowd LLP
Feb 10, 2026, 07:10 ET Einride to Appoint Former NVIDIA Executive Gary Hicok to Board of Directors
[email protected] Merger Corp. IIIEric RosenfeldChief SPAC Officer, Legato Merger Corp. III[email protected] This
More news about: Einride
Feb 10, 2026, 07:04 ET Visional Pop and FriendsWithYou Reveal 2026 Episode Lineup and Expanded Digital Presence for Happy World
Feb. 10, 2026 /PRNewswire/ -- Visional Pop, Inc., in collaboration with artist duo FriendsWithYou (Samuel Borkson and Arturo Sandoval III), today announced the 2026 rollout plan for their original IP, Happy World, along with an expanded digital presence.
More news about: Visional Pop Inc
Feb 10, 2026, 07:00 ET New REZOLVE-AD Maintenance Data in Atopic Dermatitis Demonstrate Rezpegaldesleukin Resulted in Durable and New Responses Across Key Disease Measurements with Both Monthly and Quarterly Dosing
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin is in clinical development and the risk of failure is high and can unexpectedly occur at any stage prior to regulatory approval; (iv)
More news about: Nektar Therapeutics
Feb 10, 2026, 07:00 ET Harley-Davidson Delivers Fourth Quarter and Full Year Financial Results and 2026 Outlook
develop, produce, market and sell its electric vehicles; (ii) the demand for and consumer willingness to adopt two- and three-wheeled electric vehicles; (iii) the ability of LiveWire to obtain sufficient funding from sources other than the Company to sustain its operations; and (iv) other risks and uncertainties
More news about: Harley-Davidson, Inc.
Feb 10, 2026, 07:00 ET Marriott International Reports Fourth Quarter and Full Year 2025 Results
1 "International" refers to: (i) Europe, Middle East & Africa, (ii) Greater China, (iii) Asia Pacific excluding China, and (iv) Caribbean & Latin America.
More news about: Marriott International, Inc.
Feb 10, 2026, 06:00 ET Hyperscale Data Bitcoin Treasury at 589.4502 Bitcoin
"We continue to demonstrate our dedication to our dollar-cost average strategy," stated Milton "Todd" Ault III, Executive Chairman of Hyperscale Data. "Acquiring Bitcoin through our dollar-cost average strategy has allowed us to continually lower
More news about: Hyperscale Data Inc.
Feb 10, 2026, 06:00 ET DuPont Reports Fourth Quarter and Full Year 2025 Results
to timely effect, if at all, the Aramids Divestiture and the impact on DuPont's balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva and Chemours, including the
More news about: DuPont
Feb 09, 2026, 17:31 ET Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight
strains such as Candida auris. The drug is already approved for treating Vulvovaginal Candidiasis (VVC) and is currently being evaluated in a Phase III clinical trial (NCT05178862) for invasive candidiasis and other difficult-to-treat fungal infections.Basilea Pharmaceutica's Fosmanogepix is
More news about: DelveInsight Business Research, LLP
Feb 09, 2026, 16:30 ET Danaos Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2025
in accordance with the latest requirements of the International Maritime Organization (IMO) in relation to Tier III emission standards and Energy Efficiency Design Index (EEDI) Phase III.In relation to our dry bulk fleet, we have placed orders for two Newcastlemax dry bulk carriers of approximately
More news about: Danaos Corporation
Feb 09, 2026, 16:05 ET REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II
identical to normal I2S.The BLA for RGX-121 for MPS II was supported by positive biomarker, functional and safety data from the CAMPSIITE I/II/III trial, including out to 12 months. RGX-121 has been well tolerated in all patients dosed across all phases of the CAMPSIITE trial.RGX-121 has
More news about: REGENXBIO Inc.
Feb 09, 2026, 16:05 ET Columbus McKinnon Reports 10% Sales Growth in Q3 FY26
for the fourth quarter of fiscal 2026; (ii) our ability to de-leverage the Company to a Net Leverage Ratio to below 4.0x by the end of fiscal 2028; (iii) our operational and financial targets and capital allocation priorities including our ability to generate significant free cash flow to fund these capital
More news about: Columbus McKinnon Corporation